Author(s): Mller P, Beltrami AP, Cesselli D, Pfeiffer P, Kazakov A,
Abstract Share this page
Abstract New strategies are urgently needed for the treatment of terminal heart-failure. Recently, new therapeutic strategies were developed to induce cardiac regeneration and thereby enhancing myocardial performance by using the patients own cell pool. In the quest for adequate donor cells skeletal myoblasts, bone marrow (BM) derived cells, endothelial progenitor cells (EPCs) and resident cardiac stem cells but also cytokine application were examined. This review critically discusses the recent findings in the field of endogenous adult progenitor cells and proposes new areas for future research.
This article was published in J Mol Cell Cardiol
and referenced in Journal of Stem Cell Research & Therapy